Preferred Label : Eftilagimod Alpha;
NCIt related terms : EFTILAGIMOD ALFA;
NCIt definition : A T-cell immunostimulatory factor, derived from the soluble form of the lymphocyte-activation
gene 3 (LAG-3) protein, with potential antineoplastic activity. Upon administration,
alone or in combination with tumor antigens, eftilagimod alpha binds with high affinity
to MHC class II molecules expressed by dendritic cells (DC), potentially resulting
in DC maturation, DC migration to lymph nodes, enhanced DC cross-presentation of antigens
to T cells, and antitumor cytotoxic T cell responses.;
UNII : SJ82PK3HWA;
CAS number : 1800476-36-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1800476-36-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Immufact;
Molecule name : IMP321;
Origin ID : C62509;
UMLS CUI : C4688383;
Currated CISMeF NLP mapping
- Semantic type(s)
- concept_is_in_subset
